The U.S. Die-to-Die IP market was valued at USD 0.51 billion in 2025E and is projected to reach USD 1.02 billion by 2033, growing at a CAGR of 9.17% during 2026–2033. Market growth is driven by strong ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback